Ovarian Cancer PDX Models

The CrownBio ovarian cancer patient-derived xenograft (PDX) collection consists of several models including a treatment resistant model. PDX models present a true representation of the human heterogeneity of gynecologic malignancies and provide the most accurate approach to predicting an agents efficacy prior to entering the clinic. More

PDX offer the most translational preclinical model for efficacy screening in cancer drug development. Derived directly from patient tumors and never adapted to grow in vitro, PDX models reflect the heterogeneity and diversity of the human patient population. PDX give you an accurate, predictive model of how your treatment will perform, well before entering into expensive clinical trials. CrownBio’s HuPrime® PDX models are well characterized for pathology, growth characteristics, and are also genetically/genomically annotated for gene expression, gene copy number, mutations, and fusions.
MODEL NUMBER CANCER SUBTYPE # per page
OV0243 Papillary adenocarcinomaCLICK TO VIEW
OV0250 Endometrioid adenocarcinomaCLICK TO VIEW
OV0273 NACLICK TO VIEW
OV0276 ADCCLICK TO VIEW
OV0589 NACLICK TO VIEW
OV1200 ADCCLICK TO VIEW
OV1272 cystadenomaCLICK TO VIEW
OV1286 ADCCLICK TO VIEW
OV1327 Serous papillary cystadenocarcinomaCLICK TO VIEW
OV1365 ADCCLICK TO VIEW
OV1385 CystadenomaCLICK TO VIEW
OV13950 NACLICK TO VIEW
OV1396 NACLICK TO VIEW
OV14654 N/ACLICK TO VIEW
OV14972 NACLICK TO VIEW
OV15013 NACLICK TO VIEW
OV15398 NACLICK TO VIEW
OV15612 NACLICK TO VIEW
OV15631 NACLICK TO VIEW
OV1579 NACLICK TO VIEW